Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1176/appi.neuropsych.12020044 | DOI Listing |
J Clin Psychopharmacol
August 2015
From the *Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; †Independent Consultant, Boston, MA; ‡Alkermes, Inc, Waltham, MA; and §University of Pennsylvania, School of Social Policy & Practice, Philadelphia, PA.
Pharmacological treatment is central to effective management of schizophrenia. Prescribing clinicians have an increasing array of options from which to choose, and oral antipsychotic polypharmacy is common in routine clinical practice. Practice guidelines recommend long-acting injectable (LAI) formulations, typically viewed as monotherapeutic alternatives, for patients with established nonadherence.
View Article and Find Full Text PDFJ Neuropsychiatry Clin Neurosci
September 2013
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!